Colonial Trust’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$28.4K Buy
665
+249
+60% +$13.5K ﹤0.01% 615
2026
Q1
$26.1K Sell
416
-431
-51% -$34.5K ﹤0.01% 633
2025
Q4
$80.8K Buy
847
+570
+206% +$55.9K 0.01% 456
2025
Q3
$27.1K Buy
277
+231
+502% +$23.9K ﹤0.01% 631
2025
Q2
$4.94K Hold
46
﹤0.01% 833
2025
Q1
$4.64K Sell
46
-230
-83% -$23.2K ﹤0.01% 839
2024
Q4
$24.7K Buy
276
+260
+1,625% +$22.9K ﹤0.01% 746
2024
Q3
$1.33K Buy
+16
New +$1.26K ﹤0.01% 1030
2023
Q2
Sell
-237
Closed -$11.8K 943
2023
Q1
$11.8K Buy
+237
New +$11.2K ﹤0.01% 657

Other funds holding BSX

Colonial Trust's BSX Position: Q2 2026 in Review

Colonial Trust increased its Boston Scientific (BSX) stake by 60% in Q2 2026, buying an estimated $13.5K and bringing the position to 665 shares worth $28.4K. The position accounts for ﹤0.01% of the portfolio, ranked #615.

Colonial Trust first reported a position in BSX in Q1 2023 and has held it in 9 quarters since. The position peaked at $80.8K in Q4 2025. 1,482 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Colonial Trust held 665 shares of Boston Scientific worth $28.4K as of Q2 2026.
  • Colonial Trust bought 249 Boston Scientific shares in Q2 2026, an estimated $13.5K.
  • Boston Scientific made up ﹤0.01% of Colonial Trust's portfolio in Q2 2026, its #615 holding.
  • Colonial Trust first reported a position in Boston Scientific in Q1 2023 and has held it in 9 quarters since.
  • Colonial Trust's Boston Scientific position peaked at $80.8K in Q4 2025.
  • 1,482 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Colonial Trust's 13F filing for Q2 2026, filed 11 Aug 2026.